Full Text View
Tabular View
Study Results
Related Studies
Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
This study has been completed.
Study NCT00048542   Information provided by Abbott

First Received on November 1, 2002.   Last Updated on August 18, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis, Juvenile Idiopathic
Additional conditions recognized in this trial
Arthritis
Arthritis, Juvenile Rheumatoid
More general conditions related to this trial
Arthritis, Rheumatoid
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
Double-Blind Adalimumab/Placebo
OLE BSA Adalimumab +/- MTX
OLE FD Adalimumab +/- MTX
Additional drug interventions recognized in this trial
Adalimumab
Antibodies, Monoclonal
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services